Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Isolated Syndrome (CIS)”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Large-scale testing (Phase 3)Study completedNCT00622700
What this trial is testing

Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 618
Not applicableEnded earlyNCT03692975
What this trial is testing

MRI Hippocampal Microstructure and Episodic Memory in Early Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Bordeaux 84
Not applicableStudy completedNCT04038541
What this trial is testing

Prebiotic vs Probiotic in Multiple Sclerosis

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome (CIS)
Columbia University 37
Not applicableStudy completedNCT03134573
What this trial is testing

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Who this might be right for
Multiple Sclerosis
Bayer 96
Large-scale testing (Phase 3)Study completedNCT00287079
What this trial is testing

A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated Syndrome
Merck KGaA, Darmstadt, Germany 35
Not applicableLooking for participantsNCT05010902
What this trial is testing

Pregnancy Cohort in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis (MS)Clinically Isolated Syndrome (CIS)
Charite University, Berlin, Germany 100
Large-scale testing (Phase 3)Study completedNCT00666224
What this trial is testing

Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 481
Not applicableEnrolling By InvitationNCT07183020
What this trial is testing

Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome (CIS)
Skripuletz, Thomas Prof. Dr. 1,142
Not applicableEnded earlyNCT04599023
What this trial is testing

Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Insel Gruppe AG, University Hospital Bern 182
Testing effectiveness (Phase 2)Ended earlyNCT00624468
What this trial is testing

Atacicept in Subjects With Optic Neuritis

Who this might be right for
Optic Neuritis
EMD Serono 34
Not applicableStudy completedNCT02695394
What this trial is testing

Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study

Who this might be right for
Multiple Sclerosis (MS)Clinically Isolated Syndrome (CIS)
Charite University, Berlin, Germany 60
Not applicableStudy completedNCT03408093
What this trial is testing

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

Who this might be right for
Multiple Sclerosis
Bayer 120
Large-scale testing (Phase 3)Study completedNCT00666887
What this trial is testing

Minocycline in Clinically Isolated Syndromes (CIS)

Who this might be right for
Clinically Isolated SyndromesEarly Single Relapse of Multiple Sclerosis
Dr. Luanne Metz 142
Post-approval studies (Phase 4)Study completedNCT04998851
What this trial is testing

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Hoffmann-La Roche 26
Testing effectiveness (Phase 2)Study completedNCT00094172
What this trial is testing

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 82
Post-approval studies (Phase 4)Study completedNCT02254304
What this trial is testing

Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated Syndrome
Merck KGaA, Darmstadt, Germany 106
Not applicableStudy completedNCT02308579
What this trial is testing

Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases

Who this might be right for
Clinically Isolated Syndrome (CIS)Multiple Sclerosis (MS)Other Neurological Disorders (OND)+1 more
University at Buffalo 499
Not applicableStudy completedNCT01592474
What this trial is testing

Evaluation of Brain Atrophy in CIS Patients on Avonex

Who this might be right for
Multiple Sclerosis
University at Buffalo 180
Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Early research (Phase 1)Study completedNCT01031199
What this trial is testing

Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

Who this might be right for
Positron-Emission TomographyMultiple Sclerosis
Bayer 16
Next Page